CClinicalTrials.gg
WithdrawnNCT00962130Updated Mar 20, 2018

Glucose Monitoring in Tissue Transfers

An interventional study of Continuous glucose monitoring system in Reconstructive Tissue Surgery, sponsored by University of Wisconsin, Madison. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-20.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
No patients enrolled.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine if 1) a continuous glucose monitoring system can measure glucose levels in transferred tissue during reconstructive surgery, and 2) if glucose measurements from a continuous glucose monitoring system correlate with tissue blood perfusion.

02

Conditions studied

  • Reconstructive Tissue Surgery

Keywords

  • tissue perfusion
  • reconstructive surgery
  • continuous glucose monitoring
03

In context

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • presence of a soft tissue deformity where reconstruction with a pedicled or free tissue transfer is indicated
  • age 18 and over
  • ability to follow-up post-operatively

Exclusion criteria

Exclusion Criteria:

  • age less than 18
  • prisoner status
  • inability to participate in a standard post-operative follow-up visit
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Blood Glucose Measurement

    Subjects have sensors placed on skin before surgery and these sensors will measure the subject's glucose until the third day after surgery when they are removed.

    Device: Continuous glucose monitoring system

Interventions

  • DeviceContinuous glucose monitoring system

    one or two monitors will be placed in the tissue to be transferred

06

What researchers measure

Primary outcomes

  1. Perfusion and tissue transfer outcome during reconstructive surgery predicted by continuous glucose monitoring of tissue

    Time frame: Up to three days post-op

07

Study locations

1 site
  • University of Wisconsin
    Madison, Wisconsin 53792, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00962130
Lead sponsor
University of Wisconsin, Madison
Responsible party
Sponsor
First posted
Aug 19, 2009
Start date
Aug 2009
Primary completion
Jun 2011
Completion
Jun 2011
Last update
Mar 20, 2018

Study contacts

Timothy King, MD, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion